Navigation Links
Statins decrease risk of clot-related diseases
Date:5/16/2010

ATS 2010, NEW ORLEANS Individuals at risk for clot-related diseases may benefit from taking common cholesterol-lowering drugs known as statins, according to a study conducted by researchers at the University of Connecticut.

The results of the study will be presented at the ATS 2010 International Conference in New Orleans.

"Previous clinical studies have indicated statins may play a role in lowering the risk of these conditions, but these studies have yielded variable estimates of the effect of statin therapy," said lead author Vanjul Agarwal, M.B.B.S. "In our study, we aimed to analyze and evaluate the effect of these drugs in patients with specific conditions related to vessel blockages."

While other studies have focused on the effects of specific statin drugs, Dr. Agarwal said the current analysis sought to evaluate the effect of statins as a whole. Researchers reviewed the results of 10 studies of more than 900,000 men and women evaluating the effect of statins in preventing venous thromboembolism (VTE), clots formed in the deep veins which pose a serious risk for heart attack and stroke. Dr. Agarwal noted that the current study included all types of VTE, with a focus on deep vein thrombosis (DVT), most commonly involving clots in the lower legs, and pulmonary embolism (PE), clots that form in the primary vessels of the lungs after migrating from other areas of the body, usually the legs, pelvis or, rarely, arms. According to study results, statin use benefited patients with all types of VTE, including DVT and PE.

Both PE and DVT can be asymptomatic and therefore difficult to detect, or easy to misdiagnose. According to the Centers for Disease Control, about 200,000 to 400,000 people in the U.S. have DVT and about 100,000 to 200,000 people have a PE. Nearly one-third of individuals with a PE die as a result of the condition.

Dr. Agarwal said statins are believed to decrease the risk of VTE by reducing inflammatio
'/>"/>

Contact: Keely Savoie
KSAVOIE@THORACIC.ORG
212-315-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Statins Show Promise Against Sickle Cell
2. More Evidence That Statins Cut Stroke Risk
3. Statins May Benefit Prostate Cancer Patients
4. Alternative to Statins Shows Promise
5. Statins may slow progression of multiple sclerosis, new study finds
6. Statins May Slow Progression of Multiple Sclerosis, New Study Finds
7. Do Statins Lower Male Sex Drive?
8. Statins Wont Lower Colon Cancer Risk
9. Decreased muscle strength predicts functional impairments in older adults
10. The Pill May Decrease Bone Density
11. Severe sleep apnea decreases frequency of nightmare recall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014 With the stage set ... Total Store Expo - which will be held in ... pro-pharmacy op-ed in its online opinion section, Podium. ... ” is co-authored by Steven C. Anderson, IOM, CAE, ... dean of the MCPHS University School of Pharmacy – ...
(Date:8/22/2014)... The regional economy is about to ... on the grow again. The plant will invest ... to boost production of the popular Highlander midsize sport ... investment to $4 billion. This step allows Toyota to ... flexibility to adjust its product mix to meet changing ...
(Date:8/22/2014)... (HealthDay News) -- Many Americans know little about how Ebola ... an outbreak in the United States, a new survey shows. ... that there will be a major Ebola outbreak in the ... immediate family member will get sick with the deadly virus ... of Public Health poll. However, those opinions don,t match ...
(Date:8/22/2014)... 2014 Beat Eczema , Susan ... use natural methods to completely cure the eczema symptoms ... of Shane Michaels, prompting an investigative review. , ... skin, it can still be extremely debilitating and life-altering ... intense itching and pain that it causes on the ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in the ... advanced non-small cell lung cancer (NSCLC) patients correlates well ... , EGFR tyrosine kinase inhibitor (TKI) therapy is approved ... but the standard for determining mutation status is with ... limited or not available. A more abundant and less ...
Breaking Medicine News(10 mins):Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2
... European Society for Medical Oncology is proud to announce ... their commitment to providing excellent palliative care as part ... prestigious "ESMO Designated Centers of Integrated Oncology and Palliative ... comprehensive services in supportive and palliative care. The ...
... The SwitchTM programme, ,Switch what you Do, View, and Chew, ... and vegetable consumption and lowering ,screen time,. Researchers writing in ... programme and report that it offers promise for use in ... Iowa State University, USA, worked with a team of researchers ...
... , , FRIENDSWOOD, Texas, Sept. ... which develops, manages and owns faith-based senior living facilities, today ... lender for the development of a new senior living facility ... an 82-unit, $10 million senior living facility should be available ...
... WESTFORD, Mass., Sept. 22 Cynosure, Inc. (Nasdaq: CYNO ... light-based aesthetic treatment systems, today announced that President and Chief Executive ... at the third annual Maxim Group Growth Conference in New York ... webcast live over the Internet beginning at 10:00 a.m. (ET) Tuesday, ...
... to exaggerated fears as the real threat , TUESDAY, Sept. ... dire predictions and hastily ordered vaccines, could the growing worry ... outbreak? , That notion is weighing on the minds of ... winter flu season looms. , Not only does societal panic ...
... , RADNOR, Pa., Sept. 22 Eric Hipple, ... Feeling Blue Suicide Prevention Council,s Swing into Life! Golf Tournament, Wednesday, ... former National Football League (NFL) quarterback whose ten year career was ... a divisional championship, and the most valuable NFL player award for ...
Cached Medicine News:Health News:ESMO recognizes centers of excellence in palliative care for cancer patients 2Health News:Switch program increases kids' healthy eating, reduces screen time 2Health News:TrinityCare Senior Living Announces Expansion into Louisiana 2Health News:TrinityCare Senior Living Announces Expansion into Louisiana 3Health News:Cynosure to Present at the Maxim Group Growth Conference 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 3Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 4Health News:Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 2
(Date:8/22/2014)... Aug. 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... of units of common stock and warrants at a ... $20 million, prior to deducting underwriting discounts and commissions ... and warrants are immediately separable and will be issued ... begin trading on The NASDAQ Stock Market under the ...
(Date:8/21/2014)... 2014 Nektar Therapeutics (NASDAQ: ... positive results from its Phase 3 pivotal clinical ... recombinant factor VIII (rFVIII) treatment for hemophilia A ... its primary endpoint in reducing annualized bleed rates ... on-demand arm. Top-line results from the ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... 16 After more than 10 years of research and ... of a new company to build and market a breast ... as C.U.R.E. (Computerized Ultrasound Risk Evaluation), now referred to as ... Delphinus Medical Technologies, LLC. The company has already secured sale ...
... SAN DIEGO, Nov. 16 CareFusion (NYSE: ... announced a Web-based application that provides hospitals with on-demand ... costs. , The CareFusion Knowledge Portal is a remotely ... information dashboard to review metrics and actionable data directly ...
Cached Medicine Technology:Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 2Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 4Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 5CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 2CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: